share_log

Ligand Pharmaceuticals(LGND.US) Director Sells US$77,713.38 in Common Stock

moomoo News ·  May 17 20:41

$Ligand Pharmaceuticals (LGND.US)$ Director Gray Nancy Ryan sold 934 shares of common stock on May 9, 2024 at an average price of $83.2049 for a total value of $77,713.38.

1715992901071409191.png

What is statement of changes in beneficial ownership of securities?

It is a requirement under federal securities laws that mandates individuals, including officers, directors, and those who hold more than 10% of any class of a company's securities (collectively known as "insiders"), to report their purchases, sales, and holdings of their company's securities by submitting Forms 3, 4, and 5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment